The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics. ![Global MicroRNA Market]( "Global MicroRNA Market")
The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.
The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.
The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.
The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.
MicroRNA Market Report Highlights
- Based on products & services, the services segment dominated the market with the highest revenue share of 58.8% in 2023, due to its ability to provide wide services such as isolation & purification, miRNA cDNA synthesis, profiling, localization, & quantification, functional analysis, and others
- Based on application, the cancer segment dominated the segment with the highest revenue share in 2023, due to high investments in cancer research adopting miRNA signatures
- Based on end-use, the biotechnology & pharmaceutical companies segment dominate the market with the highest revenue share in 2023, due to their ability to establish collaborations and partnerships with research institutions that allow them to access cutting-edge research and collaborate on large-scale projects
- North America dominated the global industry in 2023 owing to the presence of key market players in the region
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Products & Service Segment
1.1.1.2. Application Segment
1.1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
1.1.1. Segment Definitions
1.1.1.1. Products & Service Segment
1.1.1.2. Application Segment
1.1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
Chapter 2. MicroRNA (miRNA) Market: Executive Summary
2.1. Market Snapshot
2.2. Products and Services Snapshots
2.3. Application and End-use Snapshot
2.4. Competitive Landscape Snapshot
2.2. Products and Services Snapshots
2.3. Application and End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. MicroRNA (miRNA) Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Outbreak of COVID - 19
3.4.2. Recent innovation in application of miRNAs
3.4.2.1. Increased adoption for use as a biomarker
3.4.2.2. Therapeutic applications
3.4.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
3.4.4. The success of miRNA in clinical trials
3.4.5. Technological advancements to support nucleic acid studies
3.4.6. Exponentially declining cost of sequencing
3.5. Market Restraint Analysis
3.5.1. High cost associated with microRNA kits and other products
3.5.2. Challenges in handling RNA & in-house development of assays for microRNA detection
3.5.3. Poor reproducibility of research and specificity of products
3.5.4. Limited life science research infrastructure in emerging markets
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTLE Analysis
3.7. COVID-19 Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Outbreak of COVID - 19
3.4.2. Recent innovation in application of miRNAs
3.4.2.1. Increased adoption for use as a biomarker
3.4.2.2. Therapeutic applications
3.4.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
3.4.4. The success of miRNA in clinical trials
3.4.5. Technological advancements to support nucleic acid studies
3.4.6. Exponentially declining cost of sequencing
3.5. Market Restraint Analysis
3.5.1. High cost associated with microRNA kits and other products
3.5.2. Challenges in handling RNA & in-house development of assays for microRNA detection
3.5.3. Poor reproducibility of research and specificity of products
3.5.4. Limited life science research infrastructure in emerging markets
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTLE Analysis
3.7. COVID-19 Analysis
Chapter 4. Products & Services Estimates & Trend Analysis
4.1. MicroRNA (miRNA) Market: Products Movement Analysis
4.2. Instruments
4.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2. Technology
4.2.2.1. Technology Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.2. Real-Time PCR
4.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.3. Microarray
4.2.2.3.1. Microarray Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.4. NGS
4.2.2.4.1. NGS Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.5. Others
4.2.2.5.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3. Workflow
4.2.3.1. Workflow Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.2. Isolation & Purification
4.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.3. miRNA cDNA Synthesis
4.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.4. Profiling, Localization, & Qualification
4.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.5. Functional Analysis & Others
4.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.6. Others
4.2.3.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2. Specimen
4.3.2.1. Specimen Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.2. Whole Blood
4.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.3. Serum
4.3.2.3.1. Serum Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.4. Plasma
4.3.2.4.1. Plasma Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.5. FFPE
4.3.2.5.1. FFPE Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.6. Fresh Frozen Tissue
4.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.7. Others
4.3.2.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3. Workflow
4.3.3.1. Workflow Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.2. Isolation & Purification
4.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.3. miRNA cDNA Synthesis
4.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.4. Profiling, Localization, & Qualification
4.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.5. Functional Analysis & Others
4.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.6. Others
4.3.3.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Services
4.4.1. Service Type Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Isolation & Purification
4.4.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. miRNA cDNA Synthesis
4.4.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.4. Profiling, Localization, & Qualification
4.4.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.5. Functional Analysis
4.4.5.1. Functional Analysis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Specimen
4.5.1. Specimen Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Whole Blood
4.5.2.1. Whole Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Serum
4.5.3.1. Serum Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Plasma
4.5.4.1. Plasma Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. FFPE
4.5.5.1. FFPE Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.6. Fresh Frozen Tissue
4.5.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.7. Others
4.5.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Instruments
4.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2. Technology
4.2.2.1. Technology Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.2. Real-Time PCR
4.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.3. Microarray
4.2.2.3.1. Microarray Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.4. NGS
4.2.2.4.1. NGS Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.2.5. Others
4.2.2.5.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3. Workflow
4.2.3.1. Workflow Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.2. Isolation & Purification
4.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.3. miRNA cDNA Synthesis
4.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.4. Profiling, Localization, & Qualification
4.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.5. Functional Analysis & Others
4.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2.3.6. Others
4.2.3.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2. Specimen
4.3.2.1. Specimen Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.2. Whole Blood
4.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.3. Serum
4.3.2.3.1. Serum Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.4. Plasma
4.3.2.4.1. Plasma Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.5. FFPE
4.3.2.5.1. FFPE Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.6. Fresh Frozen Tissue
4.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2.7. Others
4.3.2.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3. Workflow
4.3.3.1. Workflow Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.2. Isolation & Purification
4.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.3. miRNA cDNA Synthesis
4.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.4. Profiling, Localization, & Qualification
4.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.5. Functional Analysis & Others
4.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3.6. Others
4.3.3.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Services
4.4.1. Service Type Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Isolation & Purification
4.4.2.1. Isolation & Purification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. miRNA cDNA Synthesis
4.4.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.4. Profiling, Localization, & Qualification
4.4.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.5. Functional Analysis
4.4.5.1. Functional Analysis Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Specimen
4.5.1. Specimen Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Whole Blood
4.5.2.1. Whole Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Serum
4.5.3.1. Serum Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Plasma
4.5.4.1. Plasma Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. FFPE
4.5.5.1. FFPE Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.6. Fresh Frozen Tissue
4.5.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5.7. Others
4.5.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Application Estimates & Trend Analysis
5.1. MicroRNA (miRNA) Market: Application Movement Analysis
5.2. Cancer
5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3. Infectious Diseases
5.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Immunological Disorder
5.4.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Cardiovascular Disease
5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Neurological Disease
5.6.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Cancer
5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3. Infectious Diseases
5.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Immunological Disorder
5.4.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Cardiovascular Disease
5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Neurological Disease
5.6.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. End-use Estimates & Trend Analysis
6.1. MicroRNA (miRNA) Market: End-use Movement Analysis
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3. Academic & Government Research Institutes
6.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Other End-users
6.4.1. Other End-users Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3. Academic & Government Research Institutes
6.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Other End-users
6.4.1. Other End-users Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. UK MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. Germany MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.4. Spain
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. Spain MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. France MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Italy MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Microrna (Mirna) Market, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Thailand MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Australia MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.2. North America
7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. UK MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. Germany MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.4. Spain
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. Spain MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. France MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Italy MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Microrna (Mirna) Market, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Thailand MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Australia MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE MicroRNA (miRNA) Market, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait MicroRNA (miRNA) Market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. Acquisition
8.2.2. Product/Service Launch
8.2.3. Partnerships/Collaborations
8.2.4. Others
8.3. Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. Thermo Fisher Scientififc, Inc
8.4.1.1. Company Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Company Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Horizon Discovery Group Co.
8.4.3.1. Company Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NanoString Technologies, Inc
8.4.4.1. Company Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Company Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Takara Bio, Inc
8.4.6.1. Company Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. LGC Limited
8.4.7.1. Company Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BioGenex
8.4.8.1. Company Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. GeneCopoeia, Inc
8.4.9.1. Company Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. New England Biolabs
8.4.10.1. Company Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.2. Strategy Mapping
8.2.1. Acquisition
8.2.2. Product/Service Launch
8.2.3. Partnerships/Collaborations
8.2.4. Others
8.3. Market Position Analysis, 2023
8.4. Company Profiles
8.4.1. Thermo Fisher Scientififc, Inc
8.4.1.1. Company Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Company Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Horizon Discovery Group Co.
8.4.3.1. Company Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NanoString Technologies, Inc
8.4.4.1. Company Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Company Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Takara Bio, Inc
8.4.6.1. Company Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. LGC Limited
8.4.7.1. Company Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BioGenex
8.4.8.1. Company Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. GeneCopoeia, Inc
8.4.9.1. Company Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. New England Biolabs
8.4.10.1. Company Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2018-2030 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 8 North America MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 11 U.S. MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 14 Canada MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 17 Europe MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 18 Europe MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 19 Europe MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 20 Europe MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 21 Germany MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 22 Germany MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 23 Germany MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 24 UK MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 25 UK MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 26 UK MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 27 France MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 28 France MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 29 France MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 30 Italy MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 31 Italy MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 32 Italy MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 33 Spain MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 34 Spain MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 35 Spain MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 36 Denmark MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 37 Denmark MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 38 Denmark MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 39 Norway MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 40 Norway MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 41 Norway MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 42 Sweden MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 43 Sweden MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 44 Sweden MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 45 Asia-Pacific MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 46 Asia-Pacific MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 47 Asia-Pacific MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 48 Asia-Pacific MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 49 Asia-Pacific MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 50 China MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 51 China MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 52 China MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 53 Japan MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 54 Japan MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 55 Japan MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 56 India MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 57 India MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 58 India MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 59 South Korea MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 60 South Korea MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 61 South Korea MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 62 Australia MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 63 Australia MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 64 Australia MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 65 Thailand MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 66 Thailand MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 67 Thailand MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 68 Latin America MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 69 Latin America MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 70 Latin America MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 71 Brazil MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 72 Brazil MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 73 Brazil MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 74 Mexico MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 75 Mexico MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 76 Mexico MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 77 Argentina MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 84 South Africa MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 90 UAE MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 93 Kuwait MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2018-2030 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 8 North America MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 11 U.S. MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 14 Canada MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 17 Europe MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 18 Europe MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 19 Europe MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 20 Europe MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 21 Germany MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 22 Germany MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 23 Germany MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 24 UK MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 25 UK MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 26 UK MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 27 France MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 28 France MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 29 France MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 30 Italy MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 31 Italy MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 32 Italy MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 33 Spain MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 34 Spain MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 35 Spain MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 36 Denmark MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 37 Denmark MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 38 Denmark MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 39 Norway MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 40 Norway MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 41 Norway MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 42 Sweden MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 43 Sweden MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 44 Sweden MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 45 Asia-Pacific MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 46 Asia-Pacific MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 47 Asia-Pacific MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 48 Asia-Pacific MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 49 Asia-Pacific MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 50 China MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 51 China MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 52 China MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 53 Japan MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 54 Japan MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 55 Japan MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 56 India MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 57 India MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 58 India MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 59 South Korea MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 60 South Korea MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 61 South Korea MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 62 Australia MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 63 Australia MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 64 Australia MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 65 Thailand MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 66 Thailand MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 67 Thailand MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 68 Latin America MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 69 Latin America MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 70 Latin America MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 71 Brazil MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 72 Brazil MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 73 Brazil MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 74 Mexico MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 75 Mexico MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 76 Mexico MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 77 Argentina MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2018-2030 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 84 South Africa MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 90 UAE MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2018-2030 (USD Million)
Table 93 Kuwait MicroRNA Market, by Products & Services s, 2018-2030 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2018-2030 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Mineral Supplements, Market Segmentation
Figure 8 Market Snapshot, 2022
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2023
Figure 15 Global MicroRNA Market: Products & Services Movement Analysis
Figure 16 Global MicroRNA Market, for Products, 2018-2030 (USD Million)
Figure 17 Global MicroRNA Market, for Instruments, 2018-2030 (USD Million)
Figure 18 Global MicroRNA Market, for Technology, 2018-2030 (USD Million)
Figure 19 Global MicroRNA Market, for Real-Time PCR, 2018-2030 (USD Million)
Figure 20 Global MicroRNA Market, for Microarray, 2018-2030 (USD Million)
Figure 21 Global MicroRNA Market, for NGS, 2018-2030 (USD Million)
Figure 22 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 23 Global MicroRNA Market, for Workflow, 2018-2030 (USD Million)
Figure 24 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 27 Global MicroRNA Market, for Functional Analysis & Others, 2018-2030 (USD Million)
Figure 28 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 29 Global MicroRNA Market, for Consumables, 2018-2030 (USD Million)
Figure 30 Global MicroRNA Market, for Specimen, 2018-2030 (USD Million)
Figure 31 Global MicroRNA Market, for Whole Blood, 2018-2030 (USD Million)
Figure 32 Global MicroRNA Market, for Serum, 2018-2030 (USD Million)
Figure 33 Global MicroRNA Market, for Plasma, 2018-2030 (USD Million)
Figure 34 Global MicroRNA Market, for FFPE, 2018-2030 (USD Million)
Figure 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018-2030 (USD Million)
Figure 36 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 37 Global MicroRNA Market, for Workflow, 2018-2030 (USD Million)
Figure 38 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 41 Global MicroRNA Market, for Functional Analysis, 2018-2030 (USD Million)
Figure 42 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 43 Global MicroRNA Market, for Services, 2018-2030 (USD Million)
Figure 44 Global MicroRNA Market, for Type, 2018-2030 (USD Million)
Figure 45 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 48 Global MicroRNA Market, for Functional Analysis, 2018-2030 (USD Million)
Figure 49 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 50 Global MicroRNA Market, for Specimen, 2018-2030 (USD Million)
Figure 51 Global MicroRNA Market, for Whole Blood, 2018-2030 (USD Million)
Figure 52 Global MicroRNA Market, for Serum, 2018-2030 (USD Million)
Figure 53 Global MicroRNA Market, for Plasma, 2018-2030 (USD Million)
Figure 54 Global MicroRNA Market, for FFPE, 2018-2030 (USD Million)
Figure 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018-2030 (USD Million)
Figure 56 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 57 Global MicroRNA Market: Application Movement Analysis
Figure 58 Global MicroRNA Market, for Cancer, 2018-2030 (USD Million)
Figure 59 Global MicroRNA Market, for Infectious Diseases, 2018-2030 (USD Million)
Figure 60 Global MicroRNA Market, for Immunological Disorder, 2018-2030 (USD Million)
Figure 61 Global MicroRNA Market, for cardiovascular disease, 2018-2030 (USD Million)
Figure 62 Global MicroRNA Market, for Neurological Disease, 2018-2030 (USD Million)
Figure 63 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 64 Global MicroRNA Market: End-Use Movement Analysis
Figure 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018-2030 (USD Million)
Figure 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018-2030 (USD Million)
Figure 67 Global MicroRNA Market, for Other end-users, 2018-2030 (USD Million)
Figure 68 Regional Marketplace: Key Takeaways
Figure 69 Regional Outlook, 2022 & 2030
Figure 70 Global MicroRNA Market: Region Movement Analysis
Figure 71 North America MicroRNA Market, 2018-2030 (USD Million)
Figure 72 U.S. MicroRNA Market, 2018-2030 (USD Million)
Figure 73 Canada MicroRNA Market, 2018-2030 (USD Million)
Figure 74 Europe MicroRNA Market, 2018-2030 (USD Million)
Figure 75 Germany MicroRNA Market, 2018-2030 (USD Million)
Figure 76 UK MicroRNA Market, 2018-2030 (USD Million)
Figure 77 France MicroRNA Market, 2018-2030 (USD Million)
Figure 78 Italy MicroRNA Market, 2018-2030 (USD Million)
Figure 79 Spain MicroRNA Market, 2018-2030 (USD Million)
Figure 80 Denmark MicroRNA Market, 2018-2030 (USD Million)
Figure 81 Norway MicroRNA Market, 2018-2030 (USD Million)
Figure 82 Sweden MicroRNA Market, 2018-2030 (USD Million)
Figure 83 Asia-Pacific MicroRNA Market, 2018-2030 (USD Million)
Figure 84 Japan MicroRNA Market, 2018-2030 (USD Million)
Figure 85 China MicroRNA Market, 2018-2030 (USD Million)
Figure 86 India MicroRNA Market, 2018-2030 (USD Million)
Figure 87 Thailand MicroRNA Market, 2018-2030 (USD Million)
Figure 88 Australia MicroRNA Market, 2018-2030 (USD Million)
Figure 89 South Korea MicroRNA Market, 2018-2030 (USD Million)
Figure 90 Latin America MicroRNA Market, 2018-2030 (USD Million)
Figure 91 Brazil MicroRNA Market, 2018-2030 (USD Million)
Figure 92 Mexico MicroRNA Market, 2018-2030 (USD Million)
Figure 93 Argentina MicroRNA Market, 2018-2030 (USD Million)
Figure 94 Middle East and Africa MicroRNA Market, 2018-2030 (USD Million)
Figure 95 South Africa MicroRNA Market, 2018-2030 (USD Million)
Figure 96 Saudi Arabia MicroRNA Market, 2018-2030 (USD Million)
Figure 97 UAE MicroRNA Market, 2018-2030 (USD Million)
Figure 98 Kuwait MicroRNA Market, 2018-2030 (USD Million)
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Mineral Supplements, Market Segmentation
Figure 8 Market Snapshot, 2022
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2023
Figure 15 Global MicroRNA Market: Products & Services Movement Analysis
Figure 16 Global MicroRNA Market, for Products, 2018-2030 (USD Million)
Figure 17 Global MicroRNA Market, for Instruments, 2018-2030 (USD Million)
Figure 18 Global MicroRNA Market, for Technology, 2018-2030 (USD Million)
Figure 19 Global MicroRNA Market, for Real-Time PCR, 2018-2030 (USD Million)
Figure 20 Global MicroRNA Market, for Microarray, 2018-2030 (USD Million)
Figure 21 Global MicroRNA Market, for NGS, 2018-2030 (USD Million)
Figure 22 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 23 Global MicroRNA Market, for Workflow, 2018-2030 (USD Million)
Figure 24 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 27 Global MicroRNA Market, for Functional Analysis & Others, 2018-2030 (USD Million)
Figure 28 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 29 Global MicroRNA Market, for Consumables, 2018-2030 (USD Million)
Figure 30 Global MicroRNA Market, for Specimen, 2018-2030 (USD Million)
Figure 31 Global MicroRNA Market, for Whole Blood, 2018-2030 (USD Million)
Figure 32 Global MicroRNA Market, for Serum, 2018-2030 (USD Million)
Figure 33 Global MicroRNA Market, for Plasma, 2018-2030 (USD Million)
Figure 34 Global MicroRNA Market, for FFPE, 2018-2030 (USD Million)
Figure 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018-2030 (USD Million)
Figure 36 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 37 Global MicroRNA Market, for Workflow, 2018-2030 (USD Million)
Figure 38 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 41 Global MicroRNA Market, for Functional Analysis, 2018-2030 (USD Million)
Figure 42 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 43 Global MicroRNA Market, for Services, 2018-2030 (USD Million)
Figure 44 Global MicroRNA Market, for Type, 2018-2030 (USD Million)
Figure 45 Global MicroRNA Market, for Isolation & Purification, 2018-2030 (USD Million)
Figure 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018-2030 (USD Million)
Figure 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018-2030 (USD Million)
Figure 48 Global MicroRNA Market, for Functional Analysis, 2018-2030 (USD Million)
Figure 49 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 50 Global MicroRNA Market, for Specimen, 2018-2030 (USD Million)
Figure 51 Global MicroRNA Market, for Whole Blood, 2018-2030 (USD Million)
Figure 52 Global MicroRNA Market, for Serum, 2018-2030 (USD Million)
Figure 53 Global MicroRNA Market, for Plasma, 2018-2030 (USD Million)
Figure 54 Global MicroRNA Market, for FFPE, 2018-2030 (USD Million)
Figure 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018-2030 (USD Million)
Figure 56 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 57 Global MicroRNA Market: Application Movement Analysis
Figure 58 Global MicroRNA Market, for Cancer, 2018-2030 (USD Million)
Figure 59 Global MicroRNA Market, for Infectious Diseases, 2018-2030 (USD Million)
Figure 60 Global MicroRNA Market, for Immunological Disorder, 2018-2030 (USD Million)
Figure 61 Global MicroRNA Market, for cardiovascular disease, 2018-2030 (USD Million)
Figure 62 Global MicroRNA Market, for Neurological Disease, 2018-2030 (USD Million)
Figure 63 Global MicroRNA Market, for Others, 2018-2030 (USD Million)
Figure 64 Global MicroRNA Market: End-Use Movement Analysis
Figure 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018-2030 (USD Million)
Figure 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018-2030 (USD Million)
Figure 67 Global MicroRNA Market, for Other end-users, 2018-2030 (USD Million)
Figure 68 Regional Marketplace: Key Takeaways
Figure 69 Regional Outlook, 2022 & 2030
Figure 70 Global MicroRNA Market: Region Movement Analysis
Figure 71 North America MicroRNA Market, 2018-2030 (USD Million)
Figure 72 U.S. MicroRNA Market, 2018-2030 (USD Million)
Figure 73 Canada MicroRNA Market, 2018-2030 (USD Million)
Figure 74 Europe MicroRNA Market, 2018-2030 (USD Million)
Figure 75 Germany MicroRNA Market, 2018-2030 (USD Million)
Figure 76 UK MicroRNA Market, 2018-2030 (USD Million)
Figure 77 France MicroRNA Market, 2018-2030 (USD Million)
Figure 78 Italy MicroRNA Market, 2018-2030 (USD Million)
Figure 79 Spain MicroRNA Market, 2018-2030 (USD Million)
Figure 80 Denmark MicroRNA Market, 2018-2030 (USD Million)
Figure 81 Norway MicroRNA Market, 2018-2030 (USD Million)
Figure 82 Sweden MicroRNA Market, 2018-2030 (USD Million)
Figure 83 Asia-Pacific MicroRNA Market, 2018-2030 (USD Million)
Figure 84 Japan MicroRNA Market, 2018-2030 (USD Million)
Figure 85 China MicroRNA Market, 2018-2030 (USD Million)
Figure 86 India MicroRNA Market, 2018-2030 (USD Million)
Figure 87 Thailand MicroRNA Market, 2018-2030 (USD Million)
Figure 88 Australia MicroRNA Market, 2018-2030 (USD Million)
Figure 89 South Korea MicroRNA Market, 2018-2030 (USD Million)
Figure 90 Latin America MicroRNA Market, 2018-2030 (USD Million)
Figure 91 Brazil MicroRNA Market, 2018-2030 (USD Million)
Figure 92 Mexico MicroRNA Market, 2018-2030 (USD Million)
Figure 93 Argentina MicroRNA Market, 2018-2030 (USD Million)
Figure 94 Middle East and Africa MicroRNA Market, 2018-2030 (USD Million)
Figure 95 South Africa MicroRNA Market, 2018-2030 (USD Million)
Figure 96 Saudi Arabia MicroRNA Market, 2018-2030 (USD Million)
Figure 97 UAE MicroRNA Market, 2018-2030 (USD Million)
Figure 98 Kuwait MicroRNA Market, 2018-2030 (USD Million)
Companies Mentioned
- Thermo Fisher Scientififc, Inc
- QIAGEN
- Horizon Discovery Group Co.
- NanoString Technologies, Inc
- Merck KGaA
- Takara Bio, Inc
- LGC Limited
- BioGenex
- GeneCopoeia, Inc
- New England Biolabs
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.58 Billion |
| Forecasted Market Value ( USD | $ 3.64 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
